Clinical Trials
2 trialsNCT06162663 2026-02-27
Double-blind Randomized Controlled Trial Comparing Suvorexant 20 mg to Placebo for Treatment of Insomnia in Cancer Survivors
Medical University of South Carolina
Phase 4 Terminated
NCT06834386 2025-05-01
Suvorexant for Insomnia to Prevent Delirium in Hospitalized Cancer Patients
Mayo Clinic
Phase 4 Withdrawn